Neurodevelopmental Disorder Clinical Trial
— DEGAOfficial title:
Dexmedetomidine Sedation Versus General Anaesthesia for Inguinal Hernia Surgery on Peri-operative Outcomes and Neurocognitive Development in Infants: A Randomized Controlled Trial
Verified date | March 2017 |
Source | KK Women's and Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective randomized controlled trial comparing dexmedetomidine sedation with caudal anaesthesia, and general sevoflurane anaesthesia with caudal anaesthesia for inguinal herniotomies in neonates and infants below 3 months of age. The investigators will compare the efficacy and adverse events associated with each of these techniques and neurodevelopmental outcomes of the infants in each group at 6 months and 2 years of age.
Status | Completed |
Enrollment | 104 |
Est. completion date | January 31, 2021 |
Est. primary completion date | July 20, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 34 Weeks to 54 Weeks |
Eligibility | Inclusion Criteria: - Infants below 3 months of age ( corrected age 54 weeks) presenting for elective inguinal hernia repair in KKH. Exclusion Criteria: - History of prematurity younger than 28 weeks gestation, - Requirement for CPAP greater than 6 cmH20 at time of surgery - Significant cardiac pathology or cardiac conduction defects - Unusually large hernia sacs - Any contraindication for caudal anesthesia - Surgeon refusal on account of anticipated prolonged or difficult surgery. |
Country | Name | City | State |
---|---|---|---|
Singapore | KK Women's and Children's Hospital | Singapore |
Lead Sponsor | Collaborator |
---|---|
KK Women's and Children's Hospital | Duke-NUS Graduate Medical School, Singapore Institute for Clinical Sciences, Singhealth Foundation |
Singapore,
Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003 Feb 1;23(3):876-82. — View Citation
Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015 Aug;115(2):171-82. doi: 10.1093/bja/aev226. Review. — View Citation
Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand. 2010 Jul;54(6):710-6. doi: 10.1111/j.1399-6576.2009.02177.x. Epub 2009 Dec 9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Surgical success rate | Success rate of surgery with assigned technique, without requiring further adjuvants. | 4 hours | |
Other | Peri-operative apnea episodes | Number of episodes of apnea intra-operatively, in PACU, and in ward. | 24 hours | |
Other | Peri-operative bradycardic episodes | Number of episodes of bradycardia intra-operatively, in PACU, and in ward. | 24 hours | |
Primary | Deferred Imitation scores at 6 months | Deferred imitation, test of declarative memory. Infants are assessed when first shown the "target" actions (DF1) and again on how well they reproduce the actions (DF2). | 6 months | |
Secondary | Bayley scores at 2 years | Bayleys scales of Infant Development version III | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02909959 -
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT02757079 -
Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental Disorders
|
Phase 3 | |
Active, not recruiting |
NCT01942525 -
Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants
|
N/A | |
Completed |
NCT00503191 -
NeuroModulation Technique Treatment of Autism
|
Phase 1 | |
Not yet recruiting |
NCT06442592 -
Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects
|
N/A | |
Completed |
NCT01783041 -
Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants
|
Phase 2/Phase 3 | |
Recruiting |
NCT01850784 -
High Energy Formula Feeding in Infants With Congenital Heart Disease
|
N/A | |
Terminated |
NCT02557191 -
Biomarkers, Neurodevelopment and Preterm Infants
|